Overview
Marco is a partner in the Firm’s Corporate/M&A group concentrating on advising corporates on their most complex M&A and corporate finance transactions, with a particular focus on cross-border M&A transactions, dual-track (M&A/IPO) processes and carve-out transactions and related pre-deal re-organizations, complex IPOs, Re-IPOs and spin-offs, rights issues and cross-border listings.
In addition to Germany and German corporates, Marco has a long track record as lead adviser on high profile transactions in Switzerland and for Swiss corporates.
When structuring and executing complex multi-jurisdictions deals, Marco benefits from his unique background with German, US and English law qualifications and the broad transactional and international experience he has gained practicing both in London for ten years and Germany for more than 15 years. In particular, having been based in London from 2000 until 2011 gives him a unique perspective when structuring and executing complex multi-jurisdictional deals.
Marco has also been one of the leading corporate finance advisers in Germany and Switzerland over the last 15 years with a very long track record of advising as lead partner on highly complex IPOs (including numerous subsidiary by listed companies), complex spin-offs by listed companies, rights issues and SEC registered and Rule 144A bond offerings (yankee bonds). In addition to advising on German law, he has practiced US law for over two decades, which gives him a unique perspective when leading international corporate finance transactions.
Experience
His recent transactions include advising:
- Lonza on its proposed USD 3 billion divestment of its Capsules & Health Ingredients (CHI) business to Lone Star Funds;
- Holcim on its EUR 1.85 billion acquisition of Xella from Lone Star;
- Holcim on the proposed EUR 840 million acquisition of Fermacell from James Hardie;
- Mercedes-Benz Group on the sale of its European vehicle leasing and fleet management services business, Athlon, to Arval, a subsidiary of BNP Paribas;
- Blacklane, a Germany-based global chauffeur service leader, on its acquisition by Uber Technologies Inc.;
- Syngenta on the sale of its barley seeds business to RAGT;
- Volkswagen on the EUR 10.1 billion sale of 25% plus one common shares in Porsche AG to Porsche SE;
- Schaeffler on the acquisition of Ewellix from Triton;
- Porsche AG and Volkswagen AG on its the EUR 9.4 billion IPO and Frankfurt listing of Porsche AG, the largest German IPO since 1996;
- Daimler and Daimler Truck on the EUR 24 billion demerger and Frankfurt listing of Daimler Truck by the Mercedes-Benz group and related pre-deal reorganization;
- Vodafone and Vantage Towers on the EUR 2.3 billion IPO and Frankfurt listing of Vantage Towers (Vodafone’s European towers business) and related pre-IPO carve-out;
- Volkswagen and TRATON on the IPO and dual Frankfurt/Nasdaq Stockholm listing of TRATON (Volkswagen’s truck and bus division) and related pre-IPO corporate re-organisation;
- the underwriting syndicate on the IPO and Nasdaq Stockholm listing of private equity group EQT.
- Brainlab SE on its aborted IPO in 2026, including pre-IPO re-organisation,
Other corporate finance transactions as lead partner include:
- IPOs/Spin-Offs: SMG Swiss Market Place, Schott Pharma, Renk, Bioversys, ThyssenKrupp Elevator (aborted subsidiary IPO by ThyssenKrupp in favour of trade sale), Siemens Healthineers (subsidiary IPO by Siemens), Covestro (subsidiary IPO by Bayer), Uniper (E.ON spin-off), Wintershall Dea (aborted), Polypeptide, Software One, medmix (Sulzer demerger), Var Energi, Metro Wholesale & Foods Specialists (demerger), OSRAM (Siemens spin-off), BUWOG (Immofinanz spin-off), Molecular Partners, Montana Aerospace, Sensirion, Sixt Leasing, Varta, Galenica Santé (subsidiary IPO by Galenica), Credit Suisse Schweiz (aborted IPO by Credit Suisse), Elkem, XXL, Alimak Hek, Qingdao Haier (first D-share listing of a Chinese blue chip on the Frankfurt Stock Exchange), RTL Group Re-IPO, RHI Magnesita, Sensirion, Polyphor, Medacta, OMV Petrom, Gjensidige Insurance, Scandic Hotels, DKSH, Van Lanschot Re-IPO, Moneta Money Bank, Bravofly, Phosagro, Sports Direct, Xchanging, Pharmstandard, Rusal, Trivago, among many others.
- Rights Issues: Bayer, Lonza, Julius Baer, Hapag Lloyd, Lenzing, Doc Morris, ams OSRAM, EFG International, Dufry, Holcim, Idorsia, Aryzta.
- US bonds: Novartis, Volkswagen, Merck & Co. KGaA, Allianz, Bayer, Hapag-Lloyd, Munich Re, Daimler Truck, Holcim, Novatek, Phosagro, Barry Callebaut, ams OSRAM, Ovako, VistaJet, British Telecommunications.